Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
HeMemics Biotechnologies, Inc
United States
- Gaithersburg, Maryland
- 26/05/2023
- Seed
- $2,000,000
Hememics uniquely uses graphene-based sensors with our patented bio preservatives to bring handheld, lab-quality testing performance to wherever needed – whether it is a farm, emergency room or battlefield. Our rugged, low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors. Our sensors can be individually programmed to detect molecular, antigen and antibody targets. We put a whole lab in your hand so you can make decisions when and wherever necessary – simplifying workflows with results within minutes.
- Industry Biotechnology Research
- Website https://www.hememics.com/
- LinkedIn https://www.linkedin.com/company/hememics-biotechnologies-inc/
Related People
John L. Warden, Jr.Founder
United States -
Chevy Chase, Maryland
Proven record of developing businesses around emerging technologies and new products. Over 25 years experience in business development, sales and capital formation of emerging technology companies.
Sales and business development executive with proven results in identifying, selling, negotiating and closing high-value agreements in pharmaceutical research, big data, chemicals and financial instruments.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)